Oncternal Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniathe Company Focuses On Developing Innovative Oncology Therapies To Meet Significant Unmet Medical Needsparticularly In Hematological Malignancies And Prostate Canceroncternal Aims To Target Proteins That Are Minimally Expressed In Normal Cellswhich Helps To Minimize Harm To Healthy Tissues While Effectively Addressing Cancer Cell Growth The Company Has A Diverse Pipeline Of Investigational Product Candidatesincluding Zilovertamaba Monoclonal Antibody Targeting The Ror1 Proteinonct 808An Autologous Car T Cell Therapyonct 534A Dual Action Androgen Receptor Inhibitorand Onct 216A Small Molecule Targeting Ets Family Transcription Factorsoncternal Has Established Partnerships With Several Prestigious Institutionsenhancing Its Research And Development Effortsthe Company Is Led By Ceo James Breitmeyer And Employs Around 30 People In The Biotechnology Sector
No conferences found for this company.
| Company Name | Oncternal Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
